CD30+ anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology

Blood

Volumn 92, Issue 10, 1998, Pages 3591-3598

  Brugieres L ^a   Le Deley, M C ^b   Pacquement, H ^b   Meguerian Bedoyan, Z ^b   Terrier Lacombe, M J ^b   Robert, A ^b   Pondarre C ^b   Leverger, G ^b   Devalck, C ^b   Rodary, C ^b   Delsol, G ^b   Hartmann, O ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION 2; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLLOW-UP STUDIES; FRANCE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, KI-1; METHOTREXATE; PREDNISONE; PROGNOSIS; PROTEIN-TYROSINE KINASES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VINBLASTINE; VINCRISTINE;

EID: 0032533908     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallensen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoïd tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
2. Kadin ME: Primary Ki-1 positive anaplastic large cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5:S25, 1994
3. Kadin ME: Ki1/CD30+ (anaplastic) large cell lymphoma: Maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol 12:88, 1994
4. Stanfeld A, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, Van Unnick J, Wright D: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
5. Harris S NL, Jaffe SE, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
6. Delsol G, Al Saati T, Gatter C, Gerdes J, Schwarting R, Caverivière P, Rigal-Huguet F, Robert A, Stein H, Mason DY: Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas: Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59, 1988
7. Egeler RM, Schmitz L, Sonneveld P, Mannival C, Nesbit ME: Malignant histiocytosis: A reassessment of cases formerly classified as histiocytic neoplasms and review of the literature. Med Pediatr Oncol 25:1, 1995
8. Morris SW, Kirstein MN, Valentine MB, Dittmer MB, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 236:1281, 1994
9. Benz-Lemoine E, Brizard A, Huret JL, Babin P, Guilhot F, Couet D, Tanzer J: Malignant histiocytosis: A specific t(2;5) (p23;q35) translocation? Review of literature. Blood 72:1045, 1988
10. Rimokh R, Magaud JP, Berger F, Samarnt J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Haematol 71:31, 1989
11. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S: A novel translocation t(2 ;5) (p23 ;q35) in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1990
12. Gordon BG, Weisenburger DD, Warkentin PI, Anderson J, Sanger WG, Bast M, Gnarra D, Vose JM, Bierman PJ, Armitage JO, Coccia PF: Peripheral T-cell lymphoma in childhood and adolescence. Cancer 71:257, 1993
13. Sandlund JT, Pui CH, Roberts WM, Santana VM, Morris SW, Berard CW, Hutchinson RE, Ribeiro RC, Mahmoud H, Crist WM: Clinicopathologic features and treatment outcome of children with large cell lymphomas and the t(2;5) (p23;q35). Blood 84:2467, 1994
14. Downing J, Shurtleff S, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger D, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris S: Molecular detection of the t(2;5) (p23;q35) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 876:284, 1996
15. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, Anderson JR, Sanger WG: Occurrence of the t(2;5) (p23;q35) in non-Hodgkin lymphoma. Blood 87:3860, 1996
16. Arber D, Sun LH, Weiss LM: Detection of the t(2;5) (p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol 27:590, 1996
17. Murphy SB: Pediatric lymphomas: Recent advances and commentary on Ki-1 positive anaplastic large-cell lymphomas of childhood. Ann Oncol 5:S1, 1994
18. Wright D, Mc Keever P, Carter R: Childhood non-Hodgkin lymphomas in the United Kingdom: Findings from the UK Children's Cancer Study. J Clin Pathol 50:128, 1997
19. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner G, Riehm H: Successful treatment for Ki-1 anaplastic large cell lymphoma of childhood: A prospective study of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
20. +) in childhood. Med Pediatr Oncol 21:402, 1993
21. Massimino M, Gasparini M, Giardini R: Ki-1 (CD30) anaplastic large-cell lymphoma in children. Ann Oncol 6:915, 1995
22. Sandlund JT, Santana V, Abromowitch M, Ribeiro R, Mahmoud H, Ayers GD, Lin JS, Hutchinson RE, Berard CW, Greenwald CA, Crist W, Pui CH: Large cell non-Hodgkin's lymphoma of childhood: Clinical characteristics and outcome. Leukemia 8:30, 1994
23. Anderson JR, Jenkin RD, Wilson JF, Kjeldsberg CR, Sposto R, Chilcote RR, Coccia PF, Exelby PR, Siegel S, Meadows AT, Hammond GD: Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Children Cancer Group. J Clin Oncol 11:1024, 1993
24. Brugières L, Caillaud JM, Patte C, Rodary C, Bernard A, Kalifa C, Hartmann O, Lemerle J: Malignant histiocytosis: Therapeutic results in 27 children treated with a single polychemotherapy regimen. Med Pediatr Oncol 17:1936, 1989
25. Lamant L, Megetto F, Al Saati A, Brugières L, Bressac-De Paillerets B, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction and P-80 immunostaining. Blood 87:284, 1996
26. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugières L, Terrier-Lacombe MJ, Halambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G: ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 91:2076, 1998
27. Pulford K, Lamant L, Morris SW, Butler L, Wood K, Stroud D, Delsol G, Mason DY: Detection of ALK and NPM-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK-1. Blood 89:1394, 1997
28. Al Saati T, Clamens S, Cohen-Knafo E, Faye JC, Prats H, Coindre JM, Wafflart J, Caverivière P, Bayard F, Delsol G: Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 55:651, 1993
29. +) lymphomas. Br J Cancer 64:321, 1991
30. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohisto-chemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741, 1991
31. Patte C, Leverger G, Perel Y, Rubie H, Otten J, Gentet JC, De Lumley L, Berendt H, Brugières L, for the SFOP: Updated results of the LMB86 protocol of the French Society of Pediatric Oncology (SFOP) for B-cell non Hodgkin's lymphoma with CNS involvement and B-ALL. Med Pediatr Oncol 18:397, 1990
32. Murphy SB: Classification, staging and results of treatment in childhood non-Hodgkin's lymphoma: Dissimilarities from lymphoma in adults. Semin Oncol 7:332, 1980
33. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860, 1971
34. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
35. Cox DR: Regression models and life tables. J R Stat Soc 34:87, 1972
36. Dixon WJ (ed): BMDP Statistical Software. Berkeley, CA, University of California, 1985, p 555
37. Schemper M, Smith TL: A note on quantifying follow-up in studies of failure time. Controlled Clin Trials 17:343, 1996
38. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
39. Orscheschek K, Mertz H, HellL J, Binder T, Bartels H, Feller AC: Large-cell anaplastic lymphoma-specific translocation [t(2;5) (p23; q35)] in Hodgkin's disease: Indication of a common pathogenesis? Lancet 345:87, 1995
40. Zinzani PL, Bendandi M, Martelli M, Falini B, Sabattini E, Amadori S, Gherlinzoni F, Martelli MF, Mandelli F, Tura S, Pileri SA: Anaplastic large cell lymphoma: Clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 8:937, 1997
41. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539, 1991
42. Schulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, Tung N, Kadin M: Primary Ki-1 anaplastic large cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
43. Fanin R, Silvestri F, Geromin A, Cerno M, Infanti L, Zaja F, Barillari G, Savignano C, Rinaldi C, Damiani D, Baccarani M: Sequential intensive treatment with the F-MACHOP regimen (±radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1) positive anaplastic large cell lymphoma in adults. Leuk Lymphoma 24:369, 1997
44. Sandlund JT, Pui CH, Santana VM, Mahmoud H, Roberts WM, Morris SW, Raimondi S, Ribeiro R, Crist WM, Lin SJ, Mao L, Berard CW, Hutchinson RE: Clinical features and treatment outcome for children with CD30+ large cell non Hodgkin's lymphoma. J Clin Oncol 12:895, 1994
45. Hutchinson RE, Banki K, Shuster JJ, Barrett D, Dieck C, Berard CW, Murphy SB, Link MP, Pick TE, Laver J, Schwenn M, Mathew P, Morris SW: Use of an anti-ALK antibody in the characterization of anaplastic large cell lymphoma of childhood. Ann Oncol 8:937, 1997
46. Hutchinson RE, Berard CW, Shuster JJ, Link MP, Pick TE, Murphy S: B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: A Pediatric Oncology Group Study. J Clin Oncol 13:2023, 1995
47. Brugières L, Le Deley MC, Pacquement H, Robert A, Tabone MD, Patte C, Delsol G, Hartmann O: Anaplastic large cell lymphoma in children: Analysis of 63 patients enrolled in two consecutive studies of the SFOP. Med Pediatr Oncol 29:357, 1997 (abstr)